Dr. Grant earned a PhD in chromatographic and mass spectrometric technologies from the University of Swansea, Wales, United Kingdom. He continued his scientific training in various industrial settings, which have included senior scientist at GSK, principal scientist at Cohesive Technologies, technical director at Eli Lilly, and director of mass spectrometry at Esoterix Endocrinology.
Dr Grant has pioneered the use of direct injection technologies, chromatographic systems multiplexing, utility of automation, and new analytical platforms for application in bioanalytical applications. His research goals are focused upon improvements in speed, sensitivity, and quality of liquid chromatography with tandem mass spectrometric (LC-MS/MS) analytical systems and assays.
Dr Grant serves as clinical chemistry chair for the American Society of Mass Spectrometry and is a member of the American Association for Clinical Chemistry.
- Providing absolute certainty without absolute quantity
- Liberate, equilibrate and automate: Immunosuppressant analysis in whole blood
- Controlling variance for self-collected plasma; anatomy, analysis and accuracy
- Proteomic genotyping: When quantitation doesn't matter, but quality still does
- Everything you wanted to know about internal standards, but were too afraid to ask
- Paint by numbers…coloring within the lines
- Genotyping apolipoprotein L1 (ApoL1) from dry plasma with proteomics
- The beauty of LC-MS/MS taming the beast of lipophilic vitamins
- Don’t know activity from ADAM(TS13)? The first LC-MS/MS assay for measuring activity of von Willebrand factor cleaving protease
- Systematic troubleshooting of assay weakness during method development